Health insurance companies are facing a growing number of lawsuits from people with hepatitis C who were denied treatment with Sovaldi because they were not sick enough.
Sovaldi Class Action Lawsuit Filed in Pennsylvania
In December 2014, the Southeastern Pennsylvania Transportation Authority (SEPTA) filed a federal class action lawsuit against Gilead Sciences regarding pricing of Sovaldi, a new drug that can cure over 90% of people with hepatitis C in just 12 weeks.
Gilead has been criticized for pricing Sovaldi at $84,000 — or about $1,000 per pill — making it too expensive for all but a tiny fraction of people with hepatitis C. The lawsuit claims that Gilead’s exorbitant pricing scheme amounts to “price-gouging”. SEPTA has spent about $2.4 million on Sovaldi for members of the health plan it funds and retirees, according to the Wall Street Journal.
The Schmidt Firm, PLLC has been recognized as one of the nation’s leading plaintiffs' law firms and handles cases in all 50 states. We are very proud of our legal achievements, but equally self-respecting of our firm's reputation for providing personal attention to each and every client we represent.
